Skip to main content

Table 4 GSEA for Early Developmental Biology GO sets.

From: Alteration of gene expression by alcohol exposure at early neurulation

Comparison

Keyword

Gene Set

Gene Set Description

Size

p-value

Exp. 2

Significant Genes

p-value

Exp. 1

Control vs ALC-NTO/ALC-NTC (see legends)

Growth,

Growth Regulation*

GO:0016049

GO:0040007

^Cell growth

^Growth

47

75

0.002

0.005

(Ctgf, Igfbp2, Emp1, Osm, Cyr61, Gap43, Crim1, Tgfb3, Igfbp7, Nov, Emp3), Gpc3, Csf1, Socs2, Bmp6, Bmp4, Inhbb, Lepre1, Wrn, Wig1, Cish

0.010

0.010

  

GO:0001558

GO:0040008

Regulation of cell growth

Regulation of growth

39

56

0.002

0.016

(Ctgf, Igfbp2, Osm, Cyr61, Gap43, Crim1, Igfbp7, Nov), Gpc3, Csf1, Socs2,

0.006

0.017

  

GO:0005520

Insulin-like growth factor binding

14

0.000

Ctgf, Igfbp2, Cyr61, Crim1, Igfbp7, Nov

0.012

 

Heart*

GO:0001525

Angiogenesis

53

0.022

Ctgf, Anxa2, Cyr61, Thbs1, Vegfa, Tie1, Elk3, Flt1, Crhr2, Vegfc, Kdr, Bmp4, Adra2b, Tnfrsf12a

0.022

 

Eye#

GO:0001654

Eye Development

26

0.040

Mab21l1, Neurod1, Neurod4, Ntrk2, Fkbp8, Bmpr1b, Crb1, Stat3, Tspan5, Pax6, Bmp4, Map3k1

0.004

 

Epigenetic factor~,^

GO:0006334

Nucleosome modeling

30

0.021

Hist3h2b, a; Hist1h3f; Hist1h1c; Hist1h2b, c; Hist1h3a; H1f0; Smarca2; Nap1l3

0.033

ALC-NTO vs ALC-NTC

Growth, Growth retardation

GO:0007173

Epidermal growth factor receptor (EGFR) signaling pathway

5

0.019

Pde6g, Egfr, Hbegf

(Enriched in ALC-NTC)

0.023

  1. ^= Gene set reduced in ALC-NTO as compared with Control.
  2. *= Gene sets reduced in ALC (all alcohol group) and ALC-NTC as compared with Control.
  3. ~= Gene set reduced in ALC as compared with Control
  4. #= Gene set reduced in ALC-NTC as compared with Control.
  5. ( ) = genes in Cell growth related GO set, which is included in Growth GO set; or genes in Regulation of Cell growth related GO set, which is included in Regulation of Growth GO set.